Prostatic cancer with rhabdomyolysis resulting from LH-RH agonist administration

I. Morita; S. Kaji; K. Tatsugami; T. Sumii

Prostatic cancer with rhabdomyolysis resulting from LH-RH agonist administration

I. Morita, S. Kaji, K. Tatsugami, T. Sumii

Research output: Contribution to journal › Article › peer-review

Abstract

An 86-year-old patient with advanced prostatic cancer who was treated with LH-RH agonist (Leuplin 3.75 mg) developed fever, malaise, fatigability and anuria 13 days after the treatment. Rhabdomyolysis was suggested by laboratory data (GOT, LDH, Mb, Aldolase, CPK). There was no predisposing factor other than LH-RH agonist as the cause of drug-induced rhabdomyolysis.

Original language	English
Pages (from-to)	149-151
Number of pages	3
Journal	IRYO - Japanese Journal of National Medical Services
Volume	50
Issue number	2
Publication status	Published - 1996
Externally published	Yes

All Science Journal Classification (ASJC) codes

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{746f3d0c25ad4053b181c20aa67740bf,

title = "Prostatic cancer with rhabdomyolysis resulting from LH-RH agonist administration",

abstract = "An 86-year-old patient with advanced prostatic cancer who was treated with LH-RH agonist (Leuplin 3.75 mg) developed fever, malaise, fatigability and anuria 13 days after the treatment. Rhabdomyolysis was suggested by laboratory data (GOT, LDH, Mb, Aldolase, CPK). There was no predisposing factor other than LH-RH agonist as the cause of drug-induced rhabdomyolysis.",

author = "I. Morita and S. Kaji and K. Tatsugami and T. Sumii",

year = "1996",

language = "English",

volume = "50",

pages = "149--151",

journal = "IRYO - Japanese Journal of National Medical Services",

issn = "0021-1699",

publisher = "Japanese Society of National Medical Services",

number = "2",

}

TY - JOUR

T1 - Prostatic cancer with rhabdomyolysis resulting from LH-RH agonist administration

AU - Morita, I.

AU - Kaji, S.

AU - Tatsugami, K.

AU - Sumii, T.

PY - 1996

Y1 - 1996

N2 - An 86-year-old patient with advanced prostatic cancer who was treated with LH-RH agonist (Leuplin 3.75 mg) developed fever, malaise, fatigability and anuria 13 days after the treatment. Rhabdomyolysis was suggested by laboratory data (GOT, LDH, Mb, Aldolase, CPK). There was no predisposing factor other than LH-RH agonist as the cause of drug-induced rhabdomyolysis.

AB - An 86-year-old patient with advanced prostatic cancer who was treated with LH-RH agonist (Leuplin 3.75 mg) developed fever, malaise, fatigability and anuria 13 days after the treatment. Rhabdomyolysis was suggested by laboratory data (GOT, LDH, Mb, Aldolase, CPK). There was no predisposing factor other than LH-RH agonist as the cause of drug-induced rhabdomyolysis.

UR - http://www.scopus.com/inward/record.url?scp=0029925033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029925033&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029925033

SN - 0021-1699

VL - 50

SP - 149

EP - 151

JO - IRYO - Japanese Journal of National Medical Services

JF - IRYO - Japanese Journal of National Medical Services

IS - 2

ER -

Prostatic cancer with rhabdomyolysis resulting from LH-RH agonist administration

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Other files and links

Fingerprint

Cite this